Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › SVRA

SUPERSTRING CAPITAL MANAGEMENT LP position in SVRA

Savara Inc · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 977,460 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 3.80% of its reported portfolio and ranking #13 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed SVRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)977.46K sh
Reported value held$6.02M
Portfolio Weight3.80%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's SVRA position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in SVRA in Q4 2023 at 814,266 shares (US$3.8M). The position peaked in Q1 2024 at 2,065,144 shares, worth US$10.3M. Across 11 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 977,460 shares valued at US$6.0M — a reduction of -608,517 shares quarter over quarter.. Notable position changes include a 154% increase in Q1 2024 (shares fell 19% over the following quarter), a 90% trim in Q2 2024 (shares rose 5% over the following quarter), a 154% increase in Q4 2024 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 814.27K $3.83M New
Q1 2024 2.07M $10.28M Add
Q2 2024 200.00K $806.00K Reduce
Q3 2024 200.00K $848.00K Hold
Q4 2024 508.34K $1.56M Add
Q1 2025 966.20K $2.68M Add
Q2 2025 1.12M $2.54M Add
Q3 2025 1.31M $4.67M Add
Q4 2025 995.35K $6.00M Reduce
Q1 2026 1.59M $8.66M Add
Q2 2026 977.46K $6.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held SVRA?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed SVRA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in SVRA?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 977.46K shares of SVRA (Savara Inc), valued at $6.02M, representing 3.80% of its reported portfolio and ranking #13.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling SVRA?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in SVRA. The position peaked in Q1 2024 at 2.07M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.